NYSE · NRC
Healthcare · Medical - Healthcare Information Services
$21.25
Up+$1.24 (+6.20%)
Updated Sep 4, 2026, 6:21 AM
SID Score
6.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
NRC closed at $21.25 after 21 trading sessions, up 9.14% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 3, 2026 | $20.22 | $21.58 | $20.22 | $21.25 | 168.25K |
| Sep 2, 2026 | $20.47 | $20.65 | $19.925 | $20.01 | 114.05K |
| Sep 1, 2026 | $20.94 | $21.385 | $20.43 | $20.44 | 71.38K |
| Aug 31, 2026 | $21.69 | $21.69 | $20.70 | $20.94 | 96.93K |
| Aug 28, 2026 | $22.05 | $22.13 | $21.805 | $21.85 | 84.32K |
| Aug 27, 2026 | $21.83 | $22.45 | $21.35 | $22.01 | 67.8K |
| Aug 26, 2026 | $21.70 | $22.125 | $21.42 | $22.00 | 125.76K |
| Aug 25, 2026 | $21.92 | $22.1799 | $21.67 | $22.02 | 53.81K |
| Aug 24, 2026 | $22.15 | $22.5204 | $21.631 | $21.92 | 72.7K |
| Aug 21, 2026 | $21.89 | $22.50 | $21.73 | $22.19 | 339.03K |
| Aug 20, 2026 | $21.69 | $22.10 | $21.365 | $21.82 | 136.76K |
| Aug 19, 2026 | $22.20 | $22.87 | $21.705 | $21.98 | 104.72K |
| Aug 18, 2026 | $21.75 | $22.99 | $21.41 | $22.01 | 111.08K |
| Aug 17, 2026 | $21.18 | $21.96 | $21.13 | $21.77 | 118.25K |
| Aug 14, 2026 | $21.34 | $21.82 | $20.84 | $21.19 | 142.81K |
| Aug 13, 2026 | $20.70 | $21.43 | $20.495 | $21.31 | 110.55K |
| Aug 12, 2026 | $21.16 | $21.39 | $19.79 | $20.61 | 171.63K |
| Aug 11, 2026 | $21.07 | $21.99 | $21.07 | $21.38 | 121.38K |
| Aug 10, 2026 | $20.34 | $21.10 | $20.34 | $20.90 | 130.55K |
| Aug 7, 2026 | $19.45 | $20.595 | $19.23 | $20.34 | 139.26K |
| Aug 6, 2026 | $19.44 | $19.734 | $19.12 | $19.47 | 110.21K |
The latest Smart Investors Daily articles mentioning NRC.
NRC research
Company profile and research snapshot.
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 29, 2026 | Citizens | Market Outperform | — |
| Jun 22, 2026 | Citizens | Market Outperform | — |
No generated briefing is available yet.
Benzinga · Aug 11, 2026
On August 7, 2026, Shane Harrison, Chief Financial Officer and principal financial officer of NRC Health, a Delaware corporation (the "Company"), tendered his resignation from the Company in order to pursue an
Yahoo · Aug 3, 2026
NRC Health's Q2 earnings per share rise year over year on higher recurring contract value and strong Governance Institute bookings, partly offset by elevated operating expenses.
Yahoo · Jul 30, 2026
LINCOLN, Neb., July 30, 2026--People know the value of time in healthcare. Whether it’s waiting weeks for an appointment or hours in an emergency department, access matters. New research from NRC Health suggests that what happens after access may matter even more.
Benzinga · Jul 29, 2026
Citizens analyst Constantine Davides maintains NRC Health (NASDAQ:NRC) with a Market Outperform and raises the price target from $23 to $26.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning NRC.
